But beware. Health and Human Services Secretary Robert F. Kennedy, Jr. has called for “conflict-free” advisory committee ...
7d
MedPage Today on MSNFDA Approves Ocular Implant for Vision-Threatening MacTelA rare, progressive neurodegenerative disease associated with loss of macular photoreceptors in the retinas, MacTel type 2 ...
With a U.S. green light for its encapsulated cell therapy technology in the bag, privately held biotech Neurotech ...
Phase 3 trials demonstrated ENCELTO significantly slowed macular photoreceptor loss in MacTel patients over 24 months.
Neurotech Pharmaceuticals’ gene therapy comes in a surgical implant, and it’s now the first FDA-approved treatment for a rare vision-loss disorder. The approval handed out on March 5 covers ...
The Laser Vision Correction Center of New Jersey is the first practice in New Jersey to offer the Valeda Light Delivery ...
"Now with an FDA-approved treatment ... allowing them the opportunity to preserve more functional vision over time." According to the prescribing information, common adverse events in the studies ...
MacTel is a rare, progressive eye disease that affects the macula and causes a gradual deterioration in central vision.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results